Cargando…
Frovatriptan plus dexketoprofen in the treatment of menstrually related migraine: an open study
At least 50 % of female migraineurs experience migraine associated with the perimenstrual period, even though they may also suffer from attacks at other times of the cycle (menstrually related migraine, MRM). MRM attacks tend to be longer and more intense than those arising in other phases of the me...
Autores principales: | Allais, Gianni, Rolando, Sara, Schiapparelli, Paola, Airola, Gisella, Borgogno, Paola, Mana, Ornella, Benedetto, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661070/ https://www.ncbi.nlm.nih.gov/pubmed/23695075 http://dx.doi.org/10.1007/s10072-013-1390-0 |
Ejemplares similares
-
Acupressure in the control of migraine-associated nausea
por: Allais, Gianni, et al.
Publicado: (2012) -
Gender-related differences in migraine
por: Allais, Gianni, et al.
Publicado: (2020) -
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura
por: Allais, Gianni, et al.
Publicado: (2014) -
Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial
por: Allais, G, et al.
Publicado: (2015) -
Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine
por: Allais, Gianni, et al.
Publicado: (2016)